SREBF1 and non-small cell lung carcinoma: In summary, as shown in schema abstract Figure 7, we herein report that the SREBP-1/hsa-miR-497-5p/SCAP/FASN oncometabolic signaling axis plays a major role in the stemness and chemoresistance of NSCLC cells.